Kendle's 3Q EPS Beats Estimates

Goldman Sachs has published a research report on Kendle International Inc. KNDL after the company reported a 3Q that was aided to the upside by lower taxes. In the report, Goldman Sachs writes "Kendle reported 3Q EPS of $0.10, vs. us/consensus at $0.07/$0.04, helped by lower tax ($0.05 vs. our model) on top-line of $83.2 mn which was slightly above us/consensus of $79.5/$81.5mn. Importantly, EBIT of $5.6 mn was above our/consensus estimates of $3.0/$2.9mn where gross profit was 13.2% better than us and SG&A of $33.1 mn (sequential decline of $2.1mn) was 5.5% over our estimate. While this suggests that KNDL is making some progress on its previously discussed cost control initiatives, we think focus will remain on new business wins which were $131.4mn (vs. us at $94mn). In the quarter, KNDL's book-to-bill of 1.5 marks the second consecutive quarter that KNDL has achieved a ratio over 1-to-1, aided by lower than expected cancellations. We maintain our Sell rating and 2010-2012E EPS given uncertainty surrounding outlook where we see risk to Street revenue forecasts which imply 4.6% growth in 2011 and appear too high given TTM book-to-bill of 1.25. CC tomorrow at 8:30am EST; dial-in: 800- 946-0709, passcode: 5419062." Goldman Sachs maintains its Sell rating and $8.50 price target. Kendle International closed yesterday at $9.51.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorAnalyst RatingsGoldman SachsHealth Carekendle internationalLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!